Archana Bommi‐Reddy

1.7k total citations · 1 hit paper
15 papers, 1.3k citations indexed

About

Archana Bommi‐Reddy is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Archana Bommi‐Reddy has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cancer Research and 3 papers in Hematology. Recurrent topics in Archana Bommi‐Reddy's work include Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Archana Bommi‐Reddy is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Archana Bommi‐Reddy collaborates with scholars based in United States, India and Germany. Archana Bommi‐Reddy's co-authors include ShiYin Foo, Bruce M. Spiegelman, Shamina M. Rangwala, Zoltàn Arany, Anthony Rosenzweig, Yanhong Ma, Marcus P. Cooper, Geoffrey D. Girnun, Kwan Hyuck Baek and Jorge L. Ruas and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

Archana Bommi‐Reddy

14 papers receiving 1.3k citations

Hit Papers

HIF-independent regulation of VEGF and angiogenesis by th... 2008 2026 2014 2020 2008 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α
    2008 869 citations Zoltàn Arany, ShiYin Foo et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Archana Bommi‐Reddy United States 9 899 412 364 145 137 15 1.3k
Joseph Murdaca France 15 888 1.0× 465 1.1× 285 0.8× 133 0.9× 105 0.8× 24 1.5k
Pauline de Zeeuw Belgium 6 620 0.7× 349 0.8× 209 0.6× 77 0.5× 68 0.5× 7 1.2k
Guo-Hua Fong United States 15 566 0.6× 519 1.3× 243 0.7× 68 0.5× 197 1.4× 15 1.1k
ShiYin Foo United States 6 689 0.8× 287 0.7× 401 1.1× 59 0.4× 123 0.9× 6 1.1k
M. Ali Behzadian United States 22 937 1.0× 212 0.5× 241 0.7× 139 1.0× 118 0.9× 35 2.0k
Marzia Scortegagna United States 16 775 0.9× 705 1.7× 206 0.6× 190 1.3× 249 1.8× 31 1.4k
De‐Long Hao China 19 702 0.8× 221 0.5× 302 0.8× 104 0.7× 56 0.4× 37 1.4k
Hitoshi Takagi Japan 28 1.2k 1.4× 236 0.6× 148 0.4× 115 0.8× 62 0.5× 85 3.4k
Rongrong Cui China 25 885 1.0× 411 1.0× 198 0.5× 226 1.6× 112 0.8× 59 1.8k
Gaëlle Laurent United States 13 1.3k 1.4× 428 1.0× 551 1.5× 207 1.4× 65 0.5× 15 2.0k

Countries citing papers authored by Archana Bommi‐Reddy

Since Specialization
Citations

This map shows the geographic impact of Archana Bommi‐Reddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Archana Bommi‐Reddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Archana Bommi‐Reddy more than expected).

Fields of papers citing papers by Archana Bommi‐Reddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Archana Bommi‐Reddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Archana Bommi‐Reddy. The network helps show where Archana Bommi‐Reddy may publish in the future.

Co-authorship network of co-authors of Archana Bommi‐Reddy

This figure shows the co-authorship network connecting the top 25 collaborators of Archana Bommi‐Reddy. A scholar is included among the top collaborators of Archana Bommi‐Reddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Archana Bommi‐Reddy. Archana Bommi‐Reddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Papadopoulos, K., Martin Gutierrez, Linda Duska, et al.. (2022). Updated Findings and Biomarker Analysis From the Ongoing Phase 1 Study of Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors. European Journal of Cancer. 174. S67–S67. 1 indexed citations
2.
Bommi‐Reddy, Archana, Esteban Terzo, Michael J. Steinbaugh, et al.. (2022). CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells. PLoS ONE. 17(3). e0262378–e0262378. 10 indexed citations
3.
Mladek, Ann C., Huihuang Yan, Shulan Tian, et al.. (2022). RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastoma. Neuro-Oncology. 24(8). 1261–1272. 17 indexed citations
4.
Gardberg, A.S., Florence Poy, Valérie Vivat, et al.. (2020). Early Drug‐Discovery Efforts towards the Identification of EP300/CBP Histone Acetyltransferase (HAT) Inhibitors. ChemMedChem. 15(11). 955–960. 14 indexed citations
5.
Wilson, Jonathan E., Chirag Patel, A.S. Gardberg, et al.. (2020). Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor. ACS Medicinal Chemistry Letters. 11(6). 1324–1329. 43 indexed citations
6.
Bommi‐Reddy, Archana, Esteban Terzo, Florence Poy, et al.. (2019). Abstract 4722: Efficacy of a novel EP300/CBP histone acetyltransferase inhibitor in hormone responsive breast cancer. 4722–4722. 1 indexed citations
7.
Gardberg, A.S., Richard Cummings, Archana Bommi‐Reddy, et al.. (2019). Make the right measurement: Discovery of an allosteric inhibition site for p300-HAT. Structural Dynamics. 6(5). 54702–54702. 7 indexed citations
8.
Bommi‐Reddy, Archana, Jonathan E. Wilson, Esteban Terzo, et al.. (2019). Abstract 4722: Efficacy of a novel EP300/CBP histone acetyltransferase inhibitor in hormone responsive breast cancer. Cancer Research. 79(13_Supplement). 4722–4722. 2 indexed citations
9.
Conery, Andrew R., Richard C. Centore, Archana Bommi‐Reddy, et al.. (2016). Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response. Cancer Research. 76(6). 1313–1319. 23 indexed citations
10.
Conery, Andrew R., Richard C. Centore, Adrianne Neiss, et al.. (2016). Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma. eLife. 5. 84 indexed citations
11.
Keller, Patricia J., Andrew R. Conery, Richard C. Centore, et al.. (2016). Abstract 4749: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma. Cancer Research. 76(14_Supplement). 4749–4749.
12.
Bommi‐Reddy, Archana & William G. Kaelin. (2010). Slaying RAS with a synthetic lethal weapon. Cell Research. 20(2). 119–121. 6 indexed citations
13.
Zhang, Qing, Jinming Gu, Lianjie Li, et al.. (2009). Control of Cyclin D1 and Breast Tumorigenesis by the EglN2 Prolyl Hydroxylase. Cancer Cell. 16(5). 413–424. 109 indexed citations
14.
Bommi‐Reddy, Archana, J. Scott Sawyer, Christoph Geisen, et al.. (2008). Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen. Proceedings of the National Academy of Sciences. 105(43). 16484–16489. 112 indexed citations
15.
Arany, Zoltàn, ShiYin Foo, Yanhong Ma, et al.. (2008). HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α. Nature. 451(7181). 1008–1012. 869 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph Murdaca Breakdown of academic impact, for papers by Pauline de Zeeuw Breakdown of academic impact, for papers by Guo-Hua Fong Breakdown of academic impact, for papers by ShiYin Foo Breakdown of academic impact, for papers by M. Ali Behzadian Breakdown of academic impact, for papers by Marzia Scortegagna Breakdown of academic impact, for papers by De‐Long Hao Breakdown of academic impact, for papers by Hitoshi Takagi Breakdown of academic impact, for papers by Rongrong Cui Breakdown of academic impact, for papers by Gaëlle Laurent
Rankless by CCL
2026